| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/24/2012 | WO2012018597A9 Compositions and methods for enhancing the effectiveness of systemic, hipec, ip, and related cancer treatments |
| 05/24/2012 | WO2012018499A3 Specific regulation of cytokine levels by hdac6 inhibitors |
| 05/24/2012 | WO2012016162A3 Compositions, methods and kits for modeling, diagnosing, and treating complement disorders |
| 05/24/2012 | WO2012016050A3 Chemoradiotherapy for kras-mutant colorectal cancer |
| 05/24/2012 | WO2012015750A3 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies |
| 05/24/2012 | WO2012015704A3 Peripherally restricted faah inhibitors |
| 05/24/2012 | WO2012014165A8 A method of managing broncho-constrictive condition |
| 05/24/2012 | WO2012010942A3 Novel pharmaceutical composition(s) of hiv protease inhibitor(s) |
| 05/24/2012 | WO2012009472A3 Structure, synthesis, and applications for oligo phenylene ethynylenes (opes) |
| 05/24/2012 | WO2012008711A3 Erlotinib dichloroacetate and anti-cancer agent comprising the same |
| 05/24/2012 | WO2012003281A3 Small-molecule-targeted protein degradation |
| 05/24/2012 | WO2012001083A3 Novel eprinomectin injectable compositions |
| 05/24/2012 | WO2011159903A3 Asenapine maleate |
| 05/24/2012 | WO2011156690A3 Methods for the development of vaccines based on oligosaccharide-oligonucleotide conjugates |
| 05/24/2012 | WO2011153323A9 Compositions and methods directed to treating liver fibrosis |
| 05/24/2012 | WO2011152671A9 Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin |
| 05/24/2012 | WO2011151722A3 Methods and compositions for oral pharmaceutical therapy |
| 05/24/2012 | WO2011133728A3 Anti-viral compounds |
| 05/24/2012 | WO2011123668A3 Stereoselective synthesis of phosphorus containing actives |
| 05/24/2012 | WO2011119288A3 Multilayer melt-extruded film |
| 05/24/2012 | WO2011051540A8 Androgen receptor modulating compounds |
| 05/24/2012 | US20120130350 Detection and treatment of autoimmune disorders |
| 05/24/2012 | US20120130303 Rate control during af using cellular intervention to modulate av node |
| 05/24/2012 | US20120130300 Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics |
| 05/24/2012 | US20120130199 Methods for Treating Chronic or Unresolvable Pain and/or Increasing the Pain Threshold in a Subject and Pharmaceutical Compositions for Use Therein |
| 05/24/2012 | US20120130147 Methods for the treatment of tumors with indane compounds |
| 05/24/2012 | US20120130144 Treatment of lung cancer with a nitrobenzamide compound in combination with a growth factor inhibitor |
| 05/24/2012 | US20120130046 Tropoelastin derivatives |
| 05/24/2012 | US20120129949 Use of Anthracene Derivatives as Anti-Infectives |
| 05/24/2012 | US20120129948 Medical implant producing wear particles with benign body response |
| 05/24/2012 | US20120129947 Amino-alcohol analogues and uses thereof |
| 05/24/2012 | US20120129946 Materials and methods for treating viral infections |
| 05/24/2012 | US20120129945 Inhibitors of cognitive decline |
| 05/24/2012 | US20120129944 Stabilized composition comprising at least one adrenergic compound |
| 05/24/2012 | US20120129943 Method of increasing or maintaining the reproductive performance of sows |
| 05/24/2012 | US20120129942 Compositions and methods for treating fungal infection of the nail |
| 05/24/2012 | US20120129941 Treprostinil treatment for interstitial lung disease and asthma |
| 05/24/2012 | US20120129940 Methods of treating autism |
| 05/24/2012 | US20120129939 Polyamine inhibitors for the treatment and prevention of parkinson's disease |
| 05/24/2012 | US20120129935 Nutrition with lipids and non-digestible saccharides |
| 05/24/2012 | US20120129934 Methods for the treatment of senile dementia of the alzheimer's type |
| 05/24/2012 | US20120129933 Ceramide dimers and use thereof as pharmaceutical preparation or cosmetic preparation |
| 05/24/2012 | US20120129932 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 05/24/2012 | US20120129931 Caffeic acid derivatives and their use in improving neuronal cell viability |
| 05/24/2012 | US20120129930 Ketone compounds and compositions for cholesterol management and related uses |
| 05/24/2012 | US20120129929 Compound used to prevent diseases caused by aquaporin deficiency |
| 05/24/2012 | US20120129927 New Anthraquinone Derivatives |
| 05/24/2012 | US20120129926 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof |
| 05/24/2012 | US20120129925 Ship 1 modulators |
| 05/24/2012 | US20120129924 Uses of sesquiterpene derivatives |
| 05/24/2012 | US20120129923 Pharmaceutical co-crystals of quercetin |
| 05/24/2012 | US20120129922 Docetaxel formulations with lipoic acid |
| 05/24/2012 | US20120129921 Method and device for producing and/or purifying polynucleotides and products obtainable thereof |
| 05/24/2012 | US20120129918 Modified oligonucleotides for telomerase inhibition |
| 05/24/2012 | US20120129917 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq) |
| 05/24/2012 | US20120129916 Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof |
| 05/24/2012 | US20120129915 Organic compositions to treat hsf1-related diseases |
| 05/24/2012 | US20120129914 Organic compositions to treat hsf1-related diseases |
| 05/24/2012 | US20120129913 dsRNA For Treating Viral Infection |
| 05/24/2012 | US20120129912 RNA Targeting in Alpha-Synucleinopathies |
| 05/24/2012 | US20120129911 Compositions and methods of targeting apolipoprotein b for the reduction of apolipoprotein c-iii |
| 05/24/2012 | US20120129910 Inhibition of Apoptosis-Specific eIF-5A(elF-5A1") with Antisense Oligonucleotides and siRNA as Anti-Inflammatory Therapeutics |
| 05/24/2012 | US20120129909 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same |
| 05/24/2012 | US20120129908 Agent For The Prophylaxis And Treatment Of Highly Pathogenic Infectious Diseases |
| 05/24/2012 | US20120129907 Histidinol dehydrogenase inhibitors, and use thereof as medicaments |
| 05/24/2012 | US20120129906 Modulators of s1p receptors |
| 05/24/2012 | US20120129905 Pharmaceutical composition |
| 05/24/2012 | US20120129904 Liquid Formulations Of Bendamustine |
| 05/24/2012 | US20120129903 Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetate, and uses thereof |
| 05/24/2012 | US20120129902 4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS |
| 05/24/2012 | US20120129901 Triterpenoid derivatives useful as antiproliferative agents |
| 05/24/2012 | US20120129900 Dual-acting antihypertensive agents |
| 05/24/2012 | US20120129898 Pharmaceutical compositions for poorly soluble drugs |
| 05/24/2012 | US20120129897 Bis heteroaryl inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129896 Thiazolidinedione analogues for the treatment of metabolic diseases |
| 05/24/2012 | US20120129895 Methods of treatment |
| 05/24/2012 | US20120129894 Alkoxy Compounds for Disease Treatment |
| 05/24/2012 | US20120129893 Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas |
| 05/24/2012 | US20120129892 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses |
| 05/24/2012 | US20120129891 Sulfone derivative |
| 05/24/2012 | US20120129890 Indole derivative or pharmaceutically acceptable salt thereof |
| 05/24/2012 | US20120129889 Non-competitive NMDA receptor antagonists |
| 05/24/2012 | US20120129888 Libraries of n-(2-oxo-1-phenylpiperidin-3-yl)sulfonamides for drug discovery |
| 05/24/2012 | US20120129887 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine |
| 05/24/2012 | US20120129886 Metalloenzyme inhibitor compounds |
| 05/24/2012 | US20120129885 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2-carboxamide, novel salt forms, and methods of use thereof |
| 05/24/2012 | US20120129884 Photochemotherapeutic heterocyclic agents having antiproliferative and antineoplastic activity |
| 05/24/2012 | US20120129883 Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation ofthe serotonin 5-ht6 receptor |
| 05/24/2012 | US20120129881 Combinations of therapeutic agents for treating cancer |
| 05/24/2012 | US20120129880 Method for determining sensitivity to irinotecan and use thereof |
| 05/24/2012 | US20120129879 Compounds and Compositions for Use in Phototherapy and in Treatment of Ocular Neovascular Disease and Cancers |
| 05/24/2012 | US20120129878 Tablet |
| 05/24/2012 | US20120129877 Use of quinazoline derivatives for neurodegenerative diseases |
| 05/24/2012 | US20120129876 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
| 05/24/2012 | US20120129874 Salt forms of organic compound |
| 05/24/2012 | US20120129873 Inhibitors of bruton's tyrosine kinase |
| 05/24/2012 | US20120129872 Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129871 Crystalline form of an inhibitor of MDM2/4 and p53 interaction |
| 05/24/2012 | US20120129870 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 05/24/2012 | US20120129869 Phosphorylation and mutations of anaplastic lymphoma kinase as a diagnostic and therapeutic target in lung cancer |